首页> 外国专利> Intra-vascular administration of particles to induce pulmonary hypertension, pulmonary hypertension syndrome, and ascites in animals

Intra-vascular administration of particles to induce pulmonary hypertension, pulmonary hypertension syndrome, and ascites in animals

机译:血管内施用颗粒物可诱发动物的肺动脉高压,肺动脉高压综合征和腹水

摘要

The invention relates to a new process for inducing pulmonary hypertension (elevated blood pressure in the pulmonary arteries) in animals, with the objective of identifying and/or eliminating susceptible individuals or families to achieve genetic improvement in agriculturally important breeds of poultry (broiler chickens and turkeys), and cattle. The invention will also be useful for animal research directed toward understanding pulmonary hypertension and its sequelae in human patients as well as in animals. Sustained pulmonary hypertension leads to pulmonary hypertension syndrome, which adversely impacts poultry production throughout the world, as well as cattle production when cattle are kept at latitudes sufficiently high to challenge blood oxygenation. In poultry, the pathophysiological progression of pulmonary hypertension syndrome leads to terminal ascites (fluid accumulation in the abdominal cavity) followed by death of the animal.
机译:本发明涉及一种在动物中诱发肺动脉高压(肺动脉中的血压升高)的新方法,其目的是鉴定和/或消除易感个体或家庭,以在农业上重要的家禽品种(肉鸡和家禽)中实现遗传改良。火鸡)和牛。本发明也将用于旨在了解人类患者以及动物中的肺动脉高压及其后遗症的动物研究。持续的肺动脉高压会导致肺动脉高压综合症,这对全世界的家禽生产以及当牛保持在足够高的纬度以挑战血液氧合的牲口时都会产生不利影响。在家禽中,肺动脉高压综合征的病理生理进展导致腹水(腹腔积液)并导致动物死亡。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号